Navigation Links
Recent in Medical Technology

MEDIHONEY(TM) Dressings Shown to Help Improve Outcomes of Non-Healing Venous Leg Ulcers in Recent Case Series

Eleven of eleven wounds healed in 6 weeks or less PRINCETON, N.J., Feb. 13 /PRNewswire-FirstCall/ -- Derma Sciences, Inc. (OTC Bulletin Board: DSCI ), a provider of advanced wound care products, announced today that its MEDIHONEY Dressings were the focus of a case series on eleven non-heal...

Rib-X Pharmaceuticals, Inc. Announces Recent and Upcoming Presentations at Scientific Conferences

NEW HAVEN, Conn., Aug. 5 /PRNewswire/ -- Rib-X Pharmaceuticals, Inc. ("Rib-X" or the "Company"), a development-stage company focused on the discovery and development of novel antibiotics for the treatment of antibiotic-resistant infections, announced today that company representatives are givi...

Marketing of Diagnostics and deCODEme(TM), Recent Progress in Drug Development to be Highlighted at deCODE R&D Event

REYKJAVIK, Iceland, June 30 /PRNewswire-FirstCall/ -- At its annual R&D event being held today in New York, deCODE genetics (Nasdaq: DCGN ) will provide an update on progress in all aspects of its business, including the commercial potential and marketing rollout for its growing range of DNA-...

Presentations From Recent Heart Rhythm Society Meeting Validate the Safety and Efficacy of Ablation Frontiers Technology in 230 Patients

Novel Catheter Ablation System also delivers remarkably shorter procedure times CARLSBAD, Calif., May 23 /PRNewswire/ -- Ablation Frontiers, Inc. today announced that four presentations at the Heart Rhythm Society's 2008 Scientific Sessions reported positive earl...

New Analysis Shows Efficacy of REMICADE(R) in Treatment of Ulcerative Colitis in Patients with Recent Disease Onset or Long-Standing Disease

A Separate Retrospective Analysis of US Employer Claims Suggests a Benefit of Anti-Tumor Necrosis Factor Therapies on Absenteeism Among Employees with Inflammatory Bowel Disease SAN DIEGO, May 20 /PRNewswire/ -- Data from a new analysis of the Active Ulcerative Colitis Tri...

Alegent Health Sees Positive Results From Recent Clinician Usability Study Collaboration With Siemens and Motion Computing

Study Outcomes Include Increased Productivity and End-User Satisfaction, Enhanced Workflow and Quality of Care Improvements ORLANDO, Fla., Feb. 25 /PRNewswire-FirstCall/ -- Today, at the Healthcare Information and Management Systems Society (HIMSS) 2008 Annual Conference and Exhibiti...

Studies Attribute Recent Increase in Multiple Myeloma Survival to Novel Therapies

WASHINGTON, Nov. 1 /PRNewswire-USNewswire/ -- Multiple myeloma is one of the most common and devastating bone marrow cancers in the U.S., but survival rates have risen dramatically over the past decade. Recent analyses suggest that this trend may be attributed to new types of drugs and aggress...

Pre-clinical Data on Recent Advances with HIV VLP Vaccine Presented at AIDS Vaccine 07 Conference

ROCKVILLE, Md., Aug. 22 /PRNewswire-FirstCall/ -- Novavax, Inc. (Nasdaq: NVAX ) announced today the oral presentation of a paper entitled "Recombinant Baculovirus Derived HIV-1 Virus-Like Particles Elicit Potent Neutralizing Antibody Responses" at the AIDS Vaccine 07 conference in Seattle by ...

Bionovo to Present Recent Findings of BZL101, Its Anti-cancer Agent, at the American Association of Cancer Research

EMERYVILLE, Calif., April 16, 2007 /PRNewswire-FirstCall/ -- Bionovo, Inc. will present findings on the mechanism of action of its anti-cancer agent BZL101, which is advancing to Phase 1/2 clinical testing for late stage breast cancer at the American Association of Cancer Research (AACR) being hel...

FDA MedWatch: Avastin (bevacizumab) and Formation of Tracheoesophageal Fistula in a Recent Clinical Study in Patients with Limited-stage Small Cell Lung Cancer

ROCKVILLE, Md., April 21, 2007-Genentech and FDA notified healthcare professionals of important new safety information regarding tracheoesophageal (TE) fistula formation in a recent clinical study in patients with limited-stage small cell lung cancer (SCLC). This multicenter, non-randomized, singl...

Further Statistical Analysis of the Recent Phase III trial on Lead Product M6G Shows Additional Benefits

* Statistically significant reduction in sedation during the early post-operative period compared to morphine * Statistically significant reduction in nausea in the female patient population compared to morphine Cambridge, UK, 8th June 2007 - CeNeS Pharmaceuticals plc (AIM: CEN), the Cambridge...

Ambrilia Highlights Encouraging Data for its HIV Integrase Inhibitor Program and Recent Developments at Annual Meeting

MONTREAL, QUEBEC--(CCNMatthews - June 14, 2007) - Ambrilia Biopharma Inc. (TSX:AMB), a biopharmaceutical company developing novel small molecules and peptides to treat infectious diseases and cancer, held its Annual General and Special Meeting today, during which the data reported yesterday on its...

Lipitor Reduced the Risk of Coronary Events by Half and Stroke by Nearly One-Third in High-Risk Patients with Type 2 Diabetes Who Experienced a Recent Stroke

CHICAGO--(BUSINESS WIRE)--Jun 25, 2007 - Pfizer announced today that Lipitor (atorvastatin calcium) Tablets 80 mg reduced the risk of stroke, coronary heart disease events and major coronary events in type 2 diabetes patients who had no known coronary heart disease but who had experienced a recent ...

Sanofi Pasteur Submits Supplemental Application for A(H1N1) Pandemic Vaccine to U.S. FDA

...r licensure of its influenza A(H1N1) 2009 monovalent vaccine. Responding to recent recommendations by the FDA, the company's supplemental application requests...nical studies of our vaccine." The supplemental application follows recent recommendations by the FDA to evaluate the influenza A(H1N1) 2009 monovalen...

Vectibix(R) in Combination With Chemotherapy Significantly Improved Progression-Free Survival in First-Line Metastatic Colorectal Cancer

...EC) reports filed by Amgen, including Amgen's most recent annual report on Form 10-K and most recent periodic reports on Form 10-Q and Form 8-K. Please refer to Amgen's most recent Forms 10-K, 10-Q and 8-K for additional informatio...

Isis Reports Strong Financial Results and Highlights for Second Quarter of 2009

...ks concerning Isis' programs are described in additional detail in Isis' annual report on Form 10-K for the year ended December 31, 2008, and its most recent quarterly report on Form 10-Q, which are on file with the SEC. Copies of these and other documents are available from the Company. In this pre...

Nektar Therapeutics Reports Second Quarter 2009 Financial Results

...rly Report on Form 10-Q for the quarter ended March 31, 2009 filed with the Securities and Exchange Commission on May 8, 2009, and the company's most recent Quarterly Report on Form 10-Q to be filed on or about August 5, 2009. Actual results could differ materially from the forward-looking statements cont...

Amgen Announces Positive Top-Line Results for Denosumab in Trial for Delay of Skeletal Related Events in Bone Metastases Patients Compared to Zometa(R)

...EC) reports filed by Amgen, including Amgen's most recent annual report on Form 10-K and most recent periodic reports on Form 10-Q and Form 8-K. Please refer to Amgen's most recent Forms 10-K, 10-Q and 8-K for additional informatio...

Video: FDA Approves INVEGA(R) SUSTENNA(TM) for the Acute and Maintenance Treatment of Schizophrenia

...total scores in the acute treatment trials and significantly delayed time to relapse vs. placebo in the longer-term maintenance study. The most recent acute symptom control study was a multi-center, randomized, placebo-controlled, double-blind, parallel-group study (n=636). All patients received a do...

Medigus and Tower Semiconductor Announce World's Smallest Medical Video Camera Based on Advanced CMOS Image Sensor

...orms 20-F, F-3, F-4 and 6-K, as were filed with the Securities and Exchange Commission (the "SEC") and the Israel Securities Authority and Jazz's most recent filings on Forms 10-K and 10-Q, as were filed with the SEC. Tower and Jazz do not intend to update, and expressly disclaim any obligation to update, t...

OPAXIO(TM) Combined with Alimta(R) Well Tolerated in Dose-Ranging Study of Patients with Advanced Non-Small Cell Lung Cancer

...k factors listed or described from time to time in CTI's filings with the Securities and Exchange Commission including, without limitation, CTI's most recent filings on Forms 10-K, 10-Q and 8-K. Except as may be required by law, CTI does not intend to update or alter its forward-looking statements whether a...

Covance Receives Highest Level of Phase I Accreditation

...n $1.7 billion, global operations in more than 25 countries, and more than 10,000 employees worldwide. Information on Covance's products and services, recent press releases, and SEC filings can be obtained through its website at www.covance.com . Statements contained in this press release, which a...

New Powder Speeds Healing of Difficult Foot Wounds

...on Americans diagnosed with diabetes. Diabetic foot ulcers are the leading cause of non-traumatic, lower-limb amputations in the United States. In a recent APMA survey, 18 percent of people with diabetes reported that they have experienced a foot sore that would not heal. This powder's successful treatmen...

Is Your Hair Taking a Break?

...ral contraceptives, iron deficiency, and chronic thyroid diseases can trigger this type of hair loss. "When I evaluate patients' hair and their recent medical history, I am able to determine if their hair loss is a result of telogen effluvium. I always tell women to be patient and that their hair nee...

European Division of Global Top 20 Pharmaceutical Company Awards Phase III Trial to DATATRAK

... 20 pharmaceutical company selecting the DATATRAK team," said Laurence Birch, DATATRAK's President and CEO. "This is yet another example of DATATRAK's recent resurgence in the marketplace, and I am confident that the DATATRAK eClinical(TM) Solution, as well as the operational team responsible for the projec...

Treatment Shows Excellent Results for Providence Tarzana Patients Following Cardiac Arrest

...t Brewster, M.D., medical director of the Emergency Department at Providence Tarzana. The hypothermia therapy has been developed and studied in recent years and now, having reviewed the evidence and the successful implementation of the program at Providence Tarzana, Providence Health & Services i...

Cryo-Cell Announces C'elle(SM) Research and Development Collaboration with Cryopraxis Cryobiology Ltd.

...l in offering any such service; any adverse effect or limitations caused by recent increases in government regulation of stem cell storage facilities; any inc...ime to time with the Securities and Exchange Commission, including the most recent Annual Report on Form 10-KSB, Quarterly Reports on Form 10-QSB and any Curr...

Cyberonics Provides Update on Depression Post-Approval Study

...lings with the Securities and Exchange Commission (SEC). For a detailed discussion of these and other cautionary statements, please refer to our most recent filings with the SEC, including our Annual Report on Form 10-K for the fiscal year ended April 24, 2009. Contact information Greg Bro...

Researchers Create First Targeted Knockout Rats Using Zinc Finger Nuclease Technology

...a number of factors. See the Companies' SEC filings, and in particular, the risk factors described in their Annual Reports on Form 10-K and their most recent report on Form 10-Q. The Companies do not undertake any obligation to update these forward-looking statements. ...

Lilly and New York City Mayor Michael R. Bloomberg Announce Lilly Agrees to be First Tenant of East River Science Park; Issue Urgent Call for Healthcare Reform that Protects Innovation and Jobs

...e its anchor tenant is evidence that our work is paying off. It also serves as a major boost to our efforts to diversify New York City's economy. In recent months, we've announced initiatives to promote entrepreneurship, develop green jobs, support nonprofits, grow the media industry and add industrial jo...

July 2009 Mayo Clinic Women's HealthSource Highlights Food Storage Safety, Energy Therapies and Vitamins and Minerals

...mune function. It's long been thought that diets rich in antioxidants, such as vitamin E, could help lower the risk of some cancers and heart disease. recent studies suggest that vitamin E supplements don't provide the same health benefits as dietary sources do and may even by harmful to health. High-dose v...

National Cancer Institute Research Identifies Unique Mechanism of Brostallicin's Anti-Tumor Effectiveness

...s listed or described from time to time in the CTI's filings with the Securities and Exchange Commission including, without limitation, the CTI's most recent filings on Forms 10-K, 10-Q and 8-K. Except as may be required by law, CTI does not intend to update or alter its forward-looking statements whether a...

Exenatide Once Weekly Provided Superior Glucose Control Compared to Lantus(R) in Head-to-Head DURATION-3 Study

...ence upon Amylin, Lilly and/or Alkermes. These and additional risks and uncertainties are described more fully in Amylin's, Lilly's and Alkermes' most recent SEC filings including their Quarterly Reports on Form 10-Q and Annual Reports on Form 10-K. Amylin, Lilly and Alkermes undertake no duty to update the...

Northern California Cancer Center's First-of-Its-Kind Research Reveals Low Socioeconomic Status Often Equals Poor Chance of Lymphoma Survival

... associated with substantially poorer survival" of follicular lymphoma in California. Although survival rates for lymphomas have improved in recent years, not all groups are experiencing improvements. The NCCC team, headed by Theresa Keegan, Ph.D., found that among all patients diagnosed with fol...

BioCryst Pharmaceuticals Reports Positive Results of Shionogi & Co. Sponsored Phase 3 Studies of i.v. Peramivir for Influenza

...y with the Securities and Exchange Commission, specifically BioCryst's most recent Annual Report on Form 10-K, most recent Registration Statement on Form S-3 (filed November 28, 2008 and subsequentl...

Cystic Fibrosis - Liposomal Tobramycin Receives Second Orphan Drug Designation Within Weeks

...ratory tract in cystic fibrosis patients has received a second orphan drug designation in the US only weeks after a first designation was granted. The recent designation relates to Burkholderia cepacia pathogens that can cause lethal infections in cystic fibrosis patients. For Axentis Pharma AG of Zurich, S...

Results From Drug Trials and New Risk Factors Announced at International Alzheimer's Conference

...th studies used Martek's algal DHA. These two studies -- and other recent Alzheimer's therapy trials -- raise the possibility that treatments must be... Phase III Alzheimer's Drug Raises Level of a Toxic Protein recent evidence suggests that the drug Dimebon may improve cognitive function in p...

Michael J. Fox Foundation Awards Over $2 Million for Validation of 10 Parkinson's Therapeutic Targets

...ers work to determine whether a molecule or mechanism of interest is a true drug target. While researchers have continued to identify novel targets in recent years through genetic, biochemical and epidemiological studies, a lack of funding for validation studies has long been a major roadblock to the effici...

deCODE Discovers Second Common Genetic Risk Factor for Atrial Fibrillation and Stroke

...sks identified in deCODE's filings with the Securities and Exchange Commission, including, without limitation, the risk factors identified in our most recent Annual Report on Form 10-K and any updates to those risk factors filed from time to time in our Quarterly Reports on Form 10-Q or Current Reports on F...

Results From Trials of DHA in Alzheimer's Disease and Age-Related Cognitive Decline

...as is standard scientific practice. "These two studies - and other recent Alzheimer's therapy trials - raise the possibility that treatments for Alzh...confirmation." "One of the issues raised by this study - and other recent Alzheimer's and mild cognitive impairment therapy trials - concerns a possi...
Other Tags
(Date:8/20/2014)... life can persist in a cold, dark world. A ... that examined waters and sediments from a shallow lake ... extreme environment supports microbial ecosystems. , The National ... has implications for life in other extreme environments, both ... are published in the current edition of the science ...
(Date:8/20/2014)... State University, the Wellcome Trust Sanger Institute and the ... Mycobacterium pinnipedii from skeletons found in Peru ... is a relative of the TB bacterium that affects ... These researchers assume that seals carried the pathogens from ... lions was unexpected" comments Sebastien Gagneux, from the Swiss ...
(Date:8/20/2014)... screening outcomes of approximately 3 million infants, a team ... the University of Massachusetts Medical School, have shown that ... successfully implemented across public health newborn screening programs. Data ... 20 issue of the Journal of the American ... of SCID in newborns is higher than previously thought ...
Breaking Biology News(10 mins):University of Tennessee research uncovers subglacial life beneath Antarctic ice sheet 2Newborn screening expansion offers early diagnosis and treatment to infants with SCID 2Newborn screening expansion offers early diagnosis and treatment to infants with SCID 3
(Date:8/20/2014)... Bronson Gray HealthDay Reporter ... extremely rare, colds, flu and other minor infections might trigger ... in children, a new study suggests. Just five out ... United States, said Dr. Heather Fullerton, lead author of the ... University of California, San Francisco Benioff Children,s Hospital. "It seems ...
(Date:8/20/2014)... NY (PRWEB) August 20, 2014 The ... firm Perkins Eastman is pleased to announce ... services in China and the surrounding ... Principal Richard Sprow AIA has relocated to ... 40-year career in healthcare planning and design and to ...
(Date:8/20/2014)... Utah (PRWEB) August 20, 2014 With 3943.8% ... 2014 list of the nation’s fastest growing companies. The Inc. ... the health care sector. Connexion Point is the #1 fastest ... centers in Medicare and Medicaid, and its clients include four ... Connexion Point employs 1,000 people and has offices and contact ...
(Date:8/20/2014)... that the amygdala stimulates stress responses in adults, ... University have found that the amygdala has an ... development of nonhuman primates. , The results are ... . , The amygdala is a region of ... to threatening situations and learning about threats. Alterations ...
(Date:8/20/2014)... -- New research reveals that, long ago, sea mammals ... of the infectious disease known as tuberculosis. Ancient ... seals and sea lions, who then spread it to ... to an international team of researchers. "Tuberculosis is ... This study and further research will help us understand ...
Breaking Medicine News(10 mins):Health News:Study Ties Colds, Flu to Rare Risk of Stroke in Kids 2Health News:Study Ties Colds, Flu to Rare Risk of Stroke in Kids 3Health News:Perkins Eastman Expands Presence in China 2Health News:Perkins Eastman Expands Presence in China 3Health News:With 3943.8% Growth, Connexion Point, a Leader in Contact Centers for Health Care, Ranks 86th on the Inc. 500 List as One of the Nation’s Fastest Growing Companies 2Health News:Maturing brain flips function of amygdala in regulating stress hormones 2Health News:Maturing brain flips function of amygdala in regulating stress hormones 3Health News:Seals, Sea Lions Helped Global Spread of TB, Study Finds 2
Other Contents